Cipla receives final approval for generic version of Brovana
Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana
Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana
Arformoterol Tartrate Inhalation Solution is for treatment of bronchoconstriction
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
The acquisition of these two brands expands Lupin's portfolio of inhalation products in the U.S.
Margins under pressure - Price erosion, shelf stock adjustments and inventory pare down in US biz impacted margins.
This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
Arformoterol Tartrate had estimated annual sales of US $ 251 million in the U.S. (IQVIA MAT December 2021)
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
The profits were bolstered by the Boehringer Ingelheim MEK program income
Subscribe To Our Newsletter & Stay Updated